About Neuropro Therapeutics
Neuropro Therapeutics is a private company based in Yachats, Oregon. It has reported $5,308,646 raised in two offerings on Form D since August 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2023 | Apr 13, 2023 | $5,092,696fully sold | 2 | $2.5M | EquityRule 506(b) | Form D ↗ |
| Jul 28, 2016 | Aug 3, 2016amended Dec 13, 2016 | $215,950of $220K target | 4 | $53,988 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $5,308,646 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Neuropro Therapeutics's Form D filed Apr 13, 2023.